THIRD ROCK VENTURES V, L.P. sold 2.1% of their position (133.62K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.38M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001193125-26-222185
10% Owner
Since Jun 2024
-133.62K
Net shares
Net seller
$5.38M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
133.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−133.62K
Price / share
$40.24
Trade value
$5.38M
% of position
2.1%
5/11/2026
6.43M→6.30M
Total
Net shares
−133.62K
Net value
-$5.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −133.62K | $40.24 | $5.38M | 2.1% | 6.43M | 6.30M |
| Total | −133.62K | -$5.38M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned969.22K
Total
969.22K indirect969.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 969.22K | Indirect |
| Total | 969.22K | 969.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported